You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Temozolomide

Showing 26 - 50 of 1,157
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Anaplastic Oligoastrocytoma, Glioblastoma Trial in Guangzhou (Temozolomide)

Recruiting
  • Anaplastic Oligoastrocytoma
  • Glioblastoma
  • Temozolomide
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Oct 27, 2022

Relapsed Neuroblastoma, Refractory Neuroblastoma Trial (Natural Killer Cells, Temozolomide, Irinotecan)

Recruiting
  • Relapsed Neuroblastoma
  • Refractory Neuroblastoma
  • Natural Killer Cells
  • +4 more
  • Columbus, Ohio
    Nationwide Children's Hospital
Oct 26, 2022

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Glioblastoma Trial (Hypofractionated radiotherapy, Conventional radiotherapy, Temozolomide)

Not yet recruiting
  • Glioblastoma
  • Hypofractionated radiotherapy
  • +2 more
  • (no location specified)
Jun 27, 2022

Locally Advanced Leiomyosarcoma, Metastatic Leiomyosarcoma, Stage III Uterine Corpus Leiomyosarcoma AJCC v8 Trial in New York

Recruiting
  • Locally Advanced Leiomyosarcoma
  • +5 more
  • New York, New York
    Columbia University/Herbert Irving Cancer Center
Jan 4, 2023

Glioblastoma Trial in Morgantown (Daratumumab)

Recruiting
  • Glioblastoma
  • Morgantown, West Virginia
    West Virginia University Cancer Institute Mary Babb Randolph Can
Dec 5, 2022

Melanoma (Skin) Trial in Philadelphia (sorafenib tosylate, temozolomide)

Completed
Has Results
  • Melanoma (Skin)
  • sorafenib tosylate
  • temozolomide
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Jun 13, 2022

Colorectal Cancer Trial in New Haven (Temozolomide + Olaparib)

Active, not recruiting
  • Colorectal Cancer
  • Temozolomide + Olaparib
  • New Haven, Connecticut
    Yale New Haven Hospital
Aug 17, 2022

Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))

Completed
Has Results
  • Malignant Glioma
  • +2 more
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022

Glioma of Brain Trial in Orange (Mirtazapine (Remeron))

Recruiting
  • Glioma of Brain
  • Mirtazapine (Remeron)
  • Orange, California
    UC Irvine Health/Chao Family Comprehensive Cancer Center
Dec 26, 2022

Glioblastoma, Glioblastoma Multiforme, Glioma, Malignant Trial in New York (Repeated Superselective Intraarterial Cerebral

Recruiting
  • Glioblastoma
  • +6 more
  • Repeated Superselective Intraarterial Cerebral infusion (SIACI) of Bevacizumab (Avastin) with Temozolomide and Radiation
  • Temozolomide and Radiation Alone
  • New York, New York
    Lenox Hill Brain Tumor Center
May 5, 2022

Glioblastoma Trial in Oklahoma City (OKN 007, Temozolomide, Photon/Proton IMRT)

Recruiting
  • Glioblastoma
  • OKN 007
  • +2 more
  • Oklahoma City, Oklahoma
    Stephenson Cancer Center, University of Oklahoma Health Sciences
Jun 17, 2022

Non Small Cell Lung Cancer, CNS Progression Trial in Aurora (Temozolomide plus Osimertinib, Temozolomide plus Lorlatinib)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • CNS Progression
  • Temozolomide plus Osimertinib
  • Temozolomide plus Lorlatinib
  • Aurora, Colorado
    University of Colorado Hospital
May 12, 2022

Platinum-Sensitive Biliary Tract Cancer Trial (Cisplatin, Gemcitabine, Oxaliplatin)

Withdrawn
  • Platinum-Sensitive Biliary Tract Cancer
  • (no location specified)
May 27, 2022

Sarcoma, Ewing, Rhabdomyosarcoma Trial run by the National Cancer Institute (NCI) (PEN-866, Vincristine, Temozolomide)

Not yet recruiting
  • Sarcoma, Ewing
  • Rhabdomyosarcoma
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Aug 24, 2022

Glioblastoma Multiforme Trial in Saint Louis (drug, procedure, radiation)

Active, not recruiting
  • Glioblastoma Multiforme
  • Saint Louis, Missouri
    Washington University School of Medicine
Jul 22, 2022

Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer

Recruiting
  • Adrenal Gland Pheochromocytoma
  • +3 more
  • Computed Tomography
  • +2 more
  • Bethesda, Maryland
  • +1 more
Jan 3, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Columbus

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Natural Killer Cell Therapy
  • Temozolomide
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 28, 2022

Primary Brain Tumor, Brain Tumor, Recurrent Trial in Durham (Fluoxetine, Temozolomide)

Not yet recruiting
  • Primary Brain Tumor
  • Brain Tumor, Recurrent
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University
Dec 20, 2022

Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

Thrombocytopenia Trial in Rochester (Avatrombopag)

Recruiting
  • Thrombocytopenia
  • Rochester, New York
    University of Rochester Medical Center
Jun 9, 2022

Glioblastoma, Glioblastoma, WHO Grade IV Trial in Gainesville (Temozolomide (TMZ), Optune System, Pembrolizumab)

Active, not recruiting
  • Glioblastoma
  • Glioblastoma, WHO Grade IV
  • Temozolomide (TMZ)
  • +2 more
  • Gainesville, Florida
    University of Florida Health
Aug 22, 2022

Glioblastoma Multiforme Trial in Montréal (Metformin)

Active, not recruiting
  • Glioblastoma Multiforme
  • MontrĂ©al, Quebec, Canada
    Montreal Neurological Institute - McGill University Health Centr
Aug 31, 2022

Glioblastoma, IDH-wildtype Trial in France, Italy (Metformin, Radiation IMRT, Temozolomide)

Not yet recruiting
  • Glioblastoma, IDH-wildtype
  • Suresnes, Hauts De Seine, France
  • +5 more
Aug 2, 2022

Ovarian Aging in Low Grade Glioma Treated With Temozolomide

Terminated
Has Results
  • Low Grade Glioma
    • San Francisco, California
      UCSF Center for Reproductive Health
    Jul 6, 2022